2 weeks ago

Alkem Q1 net profit falls 22% to Rs 520 crore

Alkem Q1 net profit falls 22% to Rs 520 crore
Alkem Laboratories’ Q1 net profit falls 22 pc to Rs 520 crore · thehansindia.com

Alkem Laboratories is a company that makes medicines.

Companies often count their earnings every three months, which is called a quarter.

In the first quarter of this financial year, Alkem earned less profit than it did one year before: Rs 520 crore instead of Rs 664 crore.

That is a drop of about 22 percent.

It is a bit surprising because Alkem actually sold more medicine than before, and its sales in India and in other countries both grew.

So why did profit go down?

Because the company had to pay a much bigger tax bill this year.

Tax is money that companies give to the government.

Alkem's managers say they are working on improving their business and investing in new areas like research and medical devices, but for now, the company is keeping less profit because of higher taxes.

Key facts

Company
Alkem Laboratories
Quarter
Q1 FY27
Net profit
Rs 520 crore (down 21.7% YoY)
Revenue from operations
Rs 3,740 crore (up 10.9% YoY)
EBITDA
Rs 766.6 crore; margin 20.5%
India sales
Rs 2,497.8 crore (up 10.3%)
International sales
Rs 1,222.3 crore (up 16%)
Tax expense
Rs 251 crore (vs Rs 103 crore a year ago)

Quotes

Sandeep Singh

Managing Director of Alkem Laboratories

“"We have started FY27 on a steady note, with healthy growth across our India and international businesses. Our India business continued to outperform the market, while the strong growth in our non-US international markets was encouraging."”
thehansindia.com

Sources

Related news